Should We Screen Oncotype DX Eligible Patients With Breast MRI?

Partin, 2011, Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer, Ann Surg Oncol, 18, 3399, 10.1245/s10434-011-1698-z Buggi, 2012, Multicentric/multifocal breast cancer with a single histotype: Is the biological characterization of all individual foci justified?, Ann Oncol, 23, 2042, 10.1093/annonc/mdr570 Toole, 2014, Oncotype dx results in multiple primary breast cancers, Breast Cancer, 8, 1 Salgado, 2015, Evolving paradigms in multifocal breast cancer, Semin Cancer Biol, 31, 111, 10.1016/j.semcancer.2014.07.002